Literature DB >> 19176597

RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.

Li Sun1, Tatsuro Ishida, Tomoyuki Yasuda, Yoko Kojima, Tomoyuki Honjo, Yasuhiko Yamamoto, Hiroshi Yamamoto, Shun Ishibashi, Ken-ichi Hirata, Yoshitake Hayashi.   

Abstract

AIMS: Receptor for advanced glycation end products (RAGE) plays a pivotal role in the genesis of diabetic vascular diseases. To further explore the mechanisms underlying atherosclerosis under non-diabetic conditions, we examined the effect of RAGE deficiency on atherosclerosis in hyperlipidaemic mice. METHODS AND
RESULTS: RAGE-/- mice were crossed with low-density lipoprotein receptor-deficient (LDLr-/-) mice to generate the double knockout (DKO) mice. After feeding with high-fat diet for 12 weeks, aortic atherosclerotic lesions were analysed histologically in these mice. Although there were no differences in serum levels of glucose and known RAGE ligands between DKO and LDLr-/- mice, DKO mice exhibited a significant decrease in the size and macrophage content in atherosclerotic lesions compared with LDLr-/- mice. Expression of intracellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the aorta was lower in DKO mice than in LDLr-/- mice. Fluorescence-based assays revealed that oxidative stress in the vessel wall was attenuated in DKO mice than in LDLr-/- mice. Cell culture experiments revealed that RAGE mediated oxidative LDL-induced activation of p42/44 mitogen-activated protein kinases and oxidative stress in macrophages.
CONCLUSION: Oxidative LDL may be a ligand of RAGE in the hyperlipidaemic state. RAGE inactivation inhibits the atherosclerosis through reducing oxLDL-induced pro-inflammatory responses and oxidative stress in hyperlipidaemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176597     DOI: 10.1093/cvr/cvp036

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  35 in total

Review 1.  The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

2.  Selective macrophage ascorbate deficiency suppresses early atherosclerosis.

Authors:  Vladimir R Babaev; Richard R Whitesell; Liying Li; MacRae F Linton; Sergio Fazio; James M May
Journal:  Free Radic Biol Med       Date:  2010-10-23       Impact factor: 7.376

Review 3.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

4.  A multicellular signal transduction network of AGE/RAGE signaling.

Authors:  Sowmya Soman; Rajesh Raju; Varot K Sandhya; Jayshree Advani; Aafaque Ahmad Khan; H C Harsha; T S Keshava Prasad; P R Sudhakaran; Akhilesh Pandey; Puneeth K Adishesha
Journal:  J Cell Commun Signal       Date:  2012-11-19       Impact factor: 5.782

Review 5.  Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.

Authors:  Ravichandran Ramasamy; Shi Fang Yan; Ann Marie Schmidt
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

6.  Ascorbic acid prevents increased endothelial permeability caused by oxidized low density lipoprotein.

Authors:  James M May; Zhi-Chao Qu
Journal:  Free Radic Res       Date:  2010-11

7.  Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report.

Authors:  Sergio Raposeiras-Roubín; Bruno K Rodiño-Janeiro; Beatriz Paradela-Dobarro; Lilian Grigorian-Shamagian; José M García-Acuña; Pablo Aguiar-Souto; Michel Jacquet-Hervet; María V Reino-Maceiras; Ezequiel Alvarez; José R González-Juanatey
Journal:  Cardiovasc Diabetol       Date:  2012-08-21       Impact factor: 9.951

Review 8.  22016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis and Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-09       Impact factor: 8.311

9.  An advanced glycation end product (AGE)-receptor for AGEs (RAGE) axis restores adipogenic potential of senescent preadipocytes through modulation of p53 protein function.

Authors:  Chih-Yu Chen; Allison Martorano Abell; Yang Soo Moon; Kee-Hong Kim
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

Review 10.  Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Biochem Pharmacol       Date:  2010-01-22       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.